Bioorganic and Medicinal Chemistry Letters p. 2056 - 2060 (2013)
Update date:2022-09-26
Topics:
Bryan, Marian C.
Falsey, James R.
Frohn, Mike
Reichelt, Andreas
Yao, Guomin
Bartberger, Michael D.
Bailis, Julie M.
Zalameda, Leeanne
Miguel, Tisha San
Doherty, Elizabeth M.
Allen, John G.
Cdc7 kinase is responsible for the initiation and regulation of DNA replication and has been proposed as a target for cancer therapy. We have identified a class of Cdc7 inhibitors based on a substituted indole core. Synthesis of focused indole and azaindole analogs yielded potent and selective 5-azaindole Cdc7 inhibitors with improved intrinsic metabolic stability (ie 36). In parallel, quantum mechanical conformational analysis helped to rationalize SAR observations, led to a proposal of the preferred binding conformation in the absence of co-crystallography data, and allowed the design of 7-azaindole 37 as a second lead in this series.
View MoreChengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
China Synchem Technology Co.,Ltd
website:http://www.cnsynchem.com
Contact:+86-0552-4929311
Address:No.217 Daqing Road
MS( MAOSHENG )Chemical CO.,LTD
Contact:+86-519-82726678.82726378
Address:TAOXI INDUSTRY ZONE JINTAN
QINGDAO NEW FLOURISH INTERNATIOANAL TRADE CO., LTD.
Contact:+86 532 80861829
Address:No. 1, Yinchuan East Road, 266061, Qingdao, China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Doi:10.1039/DT9950002111
(1995)Doi:10.1021/jm00325a002
(1965)Doi:10.1002/chem.201404498
(2014)Doi:10.1139/v67-164
(1967)Doi:10.1007/BF00580885
()Doi:10.1021/ja803341y
(2008)